16:08 EDT Palisade Bio (PALI) files to sell 8.9M shares of common stock for holders
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PALI:
- Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
- Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
- Palisade Bio announces new data from ongoing program evaluating PALI-2108
- Palisade Bio receives notice of allowance for patent of PALI-2108 in China
- Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment